ICAS ICAS logo

Quicklinks

  1. About Us

    Find out about who we are and what we do here at ICAS.

  2. Find a CA

    Search our directory of individual CAs and Member organisations by name, location and professional criteria.

  3. CA Magazine

    View the latest issues of the dedicated magazine for ICAS Chartered Accountants.

  4. Contact Us

    Get in touch with ICAS by phone, email or post, with dedicated contacts for Members, Students and firms.

Login
  • Annual renewal
  • About us
  • Contact us
  • Find a CA
  1. About us
    1. Governance
  2. Members
    1. Become a member
    2. Newly qualified
    3. Manage my membership
    4. Benefits of membership
    5. Careers support
    6. Mentoring
    7. CA Wellbeing
    8. More for Members
    9. Area networks
    10. International communities
    11. Get involved
    12. Top Young CAs
    13. Career breaks
    14. ICAS podcast
    15. Newly admitted members 2022
    16. Newly admitted members 2023
  3. CA Students
    1. Student information
    2. Student resources
    3. Learning requirements
    4. Learning updates
    5. Learning blog
    6. Totum Pro | Student discount card
    7. CA Student wellbeing
  4. Become a CA
    1. How to become a CA
    2. Routes to becoming a CA
    3. CA Stories
    4. Find a training agreement
    5. Why become a CA
    6. Qualification information
    7. University exemptions
  5. Employers
    1. Become an Authorised Training Office
    2. Resources for Authorised Training Offices
    3. Professional entry
    4. Apprenticeships
  6. Find a CA
  7. ICAS events
    1. CA Summit
  8. CA magazine
  9. Insight
    1. Finance + Trust
    2. Finance + Technology
    3. Finance + EDI
    4. Finance + Mental Fitness
    5. Finance + Leadership
    6. Finance + Sustainability
  10. Professional resources
    1. Anti-money laundering
    2. Audit and assurance
    3. Brexit
    4. Charities
    5. Coronavirus
    6. Corporate and financial reporting
    7. Business and governance
    8. Ethics
    9. Insolvency
    10. ICAS Research
    11. Pensions
    12. Practice
    13. Public sector
    14. Sustainability
    15. Tax
  11. CPD - professional development
    1. CPD courses and qualifications
    2. CPD news and updates
    3. CPD support and advice
  12. Regulation
    1. Complaints and sanctions
    2. Regulatory authorisations
    3. Guidance and help sheets
    4. Regulatory monitoring
  13. CA jobs
    1. CA jobs partner: Rutherford Cross
    2. Resources for your job search
    3. Advertise with CA jobs
    4. Hays | A Trusted ICAS CA Jobs Partner
    5. Azets | What's your ambition?
  14. Work at ICAS
    1. Business centres
    2. Meet our team
    3. Benefits
    4. Vacancies
    5. Imagine your career at ICAS
  15. Contact us
    1. Technical and regulation queries
    2. ICAS logo request

Bruce Pritchard CA and Sophie Baillie CA discuss finance professionals in pharma

Meeting of Minds
  • LinkedIn (opens new window)
  • Twitter (opens new window)
By CA magazine

2 December 2020

  • Bruce Pritchard CA is CEO at Liminal BioSciences | Qualified 1996
  • Sophie Baillie CA is Head of Finance & Operations, Weatherden | Qualified 2014

In a new series, CA magazine brings together ICAS Deputy President Bruce Pritchard CA and Sophie Baillie CA to hear how the life sciences sector has evolved – and how the roles of CAs have changed along with it.

Read December/January's CA magazine now

Bruce Pritchard CA: I stumbled into the life sciences industry while going through my CA training. I was the Senior and Audit Manager on one of our firm’s largest clients, a veterinary disease research and drug development organisation. They were advertising for a group financial controller. I was slightly underqualified in terms of the spec, but the CEO encouraged me to apply.

Sophie Baillie CA: My story is a bit different – I studied chemistry at university. The next stage would have been to do a PhD and continue in academia. I really loved the theory of science but I didn’t myself particularly like the lab work. So, when I graduated, I chose to train as an accountant.

BP: I think I was very focused on being an accountant in industry. Joining the life sciences sector gave me a feel for that entrepreneurial end of business and deal making and deal doing. It really sparked my love of the corporate finance world. And those skillsets led to me being headhunted for subsequent rules.

SB: My draw was specifically towards the science. I remember starting at KPMG with the mindset that I would train as an accountant, and on qualification I would then go back into industry and perhaps work in a large pharmaceutical company. That didn’t quite happen when I qualified and I moved to a couple of boutique accounting firms. The work was interesting but I was increasingly missing the science. In my current role, it’s very interesting to work with all of our clients and hear about the science that they’re doing and get to use and engage my brain in that way as well.

A background in science gives you knowledge to fall back on - but much of your learning will be done on the job

Sophie Baillie CA

BP: The CA qualification really offers that flexibility to move and try new things. It is a highly recognised qualification in industry and on an international scale too. Any chartered accountancy qualification is a badge of quality, but the CA training is very rigorous and especially well respected as a result.

It’s also important to note that, at ICAS, we have made ethics a core part of the CA qualification. It is not just an educational topic, it flows through all aspects of a business. It’s particularly relevant in the life sciences industry – when we must consider questions around animal testing, human clinical trials and pricing.

SB: That ethics training is something I keep in mind every day at work. It also depends on your area of the industry. I work for a consulting company, so, unlike Bruce’s company, we are not ourselves the sponsor of any drug or medicine, but we are working really closely with those that are. And we want to give them the best value possible for their money.

BP: It’s a very challenging area. We’ve all heard horror stories of drugs and treatments being priced at ludicrous levels. The reality is that in some instances that’s justified because of the cost of developing the drug. In others, it is just corporate misbehaviour. Unfortunately, the whole industry gets tarred with that brush as a result.

SB: As well as demanding the highest levels of ethics, there is an important technical element to working in the industry. As CAs, we’re trained to interpret data and use it to create meaningful metrics that the rest of the business can use. You really need to drive efficiencies because of the limited investment you might have and the need to reach certain goals before investors might release the next tranche of funding.

BP: I think it’s a matter of combining both soft skills and analytical skills. The life sciences and pharmaceutical industry is enormously regulated, probably more so than any other industry from a health and safety perspective. Therefore, flowing through everything that we do needs to be a rigour around accuracy, review, checking, so CAs will find that they actually slot very well into the space.

I started as CFO of a subsidiary company and I have ended up as CEO of the group. It shows that as CAs, we have become integral to the business

Bruce Pritchard CA

SB: Being a CA means that you have that broad grounding in financial knowledge and business, and it brings in legal aspects as well. It encourages you to think in a much broader sense about businesses.

I do think that having a grounding in science helps in this industry, too. It gives you something to fall back on when you need to be able to understand scientific concepts, and it really gives you an element of credibility at the start of your career. That said, every biotech company is working on something quite different, so you will find that you learn on the job as well.

BP: I don’t necessarily think that someone moving into this industry needs to have a scientific background. It would depend on the scale of the organisation and the seniority of the role.

If you’re in a larger organisation and are purely focused on inward-facing financials, you probably don’t need any scientific knowledge other than what you pick up along the way. Where your role changes to being outward facing, particularly if it involves investor relations and capital markets activity, that’s when you have to understand the science a bit more. I’ve had to build my own understanding. Investors expect me to be able to interpret clinical data or to talk about a molecule and its mechanism of action. You have to know enough to convince the investors that you’re fit to be running the organisation.

SB: The responsibilities of CAs are also determined by the market landscape. The life sciences space is increasingly driven by external collaboration, whether that’s M&A or licensing or partnering opportunities. We increasingly need those people with financial expertise and a great grounding in business to drive that forward and structure those opportunities in the right way.

The model is also changing from the R&D being taken on by the large pharma companies to a much more scattered landscape with lots of smaller ones. With smaller headcounts, as the finance person you have a much more prominent position in the business and will be sitting at the leadership table making those crucial decisions.

BP: I think I’ve experienced that change in my career. I started in my business as CFO of a subsidiary company and I’ve ended up as CEO of the group. It shows that, as CAs, we have become integral to the business as we bring the right set of skills. We’re trained to analyse, interpret and act upon information to make solid financial and business judgements, and that is very much respected in the industry.


To register your interest in taking part in “Meeting of minds”, please contact CA magazine.

2-23-totumpro 2-23-totumpro
ICAS logo

Footer links

  • Contact us
  • Terms and conditions
  • Modern slavery statement
  • Privacy notice
  • CA magazine

Connect with ICAS

  • Facebook (opens new window) Facebook Icon
  • Twitter (opens new window) Twitter Icon
  • LinkedIn (opens new window) LinkedIn Icon
  • Instagram (opens new window) Instagram Icon

ICAS is a member of the following bodies

  • Consultative Committee of Accountancy Bodies (opens new window) Consultative Committee of Accountancy Bodies logo
  • Chartered Accountants Worldwide (opens new window) Chartered Accountants Worldwide logo
  • Global Accounting Alliance (opens new window) Global Accounting Alliance
  • International Federation of Accountants (opens new window) IFAC
  • Access Accountancy (opens new window) Access Acountancy

Charities

  • ICAS Foundation (opens new window) ICAS Foundation
  • SCABA (opens new window) scaba

Accreditations

  • ISO 9001 - RGB (opens new window)
© ICAS 2022

The mark and designation “CA” is a registered trade mark of The Institute of Chartered Accountants of Scotland (ICAS), and is available for use in the UK and EU only to members of ICAS. If you are not a member of ICAS, you should not use the “CA” mark and designation in the UK or EU in relation to accountancy, tax or insolvency services. The mark and designation “Chartered Accountant” is a registered trade mark of ICAS, the Institute of Chartered Accountants of England and Wales and Chartered Accountants Ireland. If you are not a member of one of these organisations, you should not use the “Chartered Accountant” mark and designation in the UK or EU in relation to these services. Further restrictions on the use of these marks also apply where you are a member.

ICAS logo

Our cookie policy

ICAS.com uses cookies which are essential for our website to work. We would also like to use analytical cookies to help us improve our website and your user experience. Any data collected is anonymised. Please have a look at the further information in our cookie policy and confirm if you are happy for us to use analytical cookies: